Cassaday & Co Wealth Management
SPRB icon

Cassaday & Co Wealth Management’s Spruce Biosciences SPRB Stock Holding History

Cassaday & Co Wealth Management’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$98 Hold
2
– – ﹤0.01% 1227
2026
Q2 		$108 Hold
2
– – ﹤0.01% 1263
2026
Q1 		$130 Buy
+2
New +$138 ﹤0.01% 1312

Other funds holding SPRB

SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Pinnacle Wealth Planning Services
Pinnacle Wealth Planning Services Mansfield, Ohio $1.03B AUM 22.32% 1-Year Est. Return
Parkside Financial Bank & Trust
Parkside Financial Bank & Trust Saint Louis, Missouri $1.51B AUM 17.86% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
SJS Investment Consulting
SJS Investment Consulting Sylvania, Ohio $993M AUM 16.29% 1-Year Est. Return
Root Financial Partners
Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Cassaday & Co Wealth Management's SPRB Position: Q3 2026 in Review

Cassaday & Co Wealth Management held its Spruce Biosciences (SPRB) position steady in Q3 2026 at 2 shares worth $98. The position accounts for ﹤0.01% of the portfolio, ranked #1227.

Cassaday & Co Wealth Management first reported a position in SPRB in Q1 2026 and has held it in 3 quarters since. The position peaked at $130 in Q1 2026. 9 funds tracked by Wall St. Rank hold SPRB as of Q3 2026.

  • Cassaday & Co Wealth Management held 2 shares of Spruce Biosciences worth $98 as of Q3 2026.
  • Cassaday & Co Wealth Management left its Spruce Biosciences share count unchanged in Q3 2026.
  • Spruce Biosciences made up ﹤0.01% of Cassaday & Co Wealth Management's portfolio in Q3 2026, its #1227 holding.
  • Cassaday & Co Wealth Management first reported a position in Spruce Biosciences in Q1 2026 and has held it in 3 quarters since.
  • Cassaday & Co Wealth Management's Spruce Biosciences position peaked at $130 in Q1 2026.
  • 9 funds tracked by Wall St. Rank held Spruce Biosciences as of Q3 2026.

Based on Cassaday & Co Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.